Monte Rosa Therapeutics, Inc.
(GLUE - NASDAQ)
19,29 USD
📋 Profilo Aziendale

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins.

|